Evidence map›Paper›PMID 31866205›Full record

ArticleDevelopmental cell2020

Low-Level Saturated Fatty Acid Palmitate Benefits Liver Cells by Boosting Mitochondrial Metabolism via CDK1-SIRT3-CPT2 Cascade.

Lin Liu, Bowen Xie, Ming Fan, Demet Candas-Green, Joy X Jiang, Ryan Wei, Yinsheng Wang, Hong-Wu Chen, Yiyang Hu, Jian Jian Li

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Lin LiuDepartment of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Institute of Liver Diseases, Shuguan Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Bowen XieDepartment of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA.
Ming FanDepartment of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA.
Demet Candas-GreenDepartment of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA.
Joy X JiangDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, School of Medicine, University of California, Davis, Sacramento, CA, USA.
Ryan WeiDepartment of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Yinsheng WangDepartment of Chemistry, University of California, Riverside, Riverside, CA, USA.
Hong-Wu ChenDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USA; Comprehensive Cancer Center, University of California, Davis, Sacramento, CA, USA.
Yiyang HuInstitute of Liver Diseases, Shuguan Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Jian Jian LiDepartment of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Comprehensive Cancer Center, University of California, Davis, Sacramento, CA, USA. Electronic address: jijli@ucdavis.edu.
University of California, Davis · USShanghai University of Traditional Chinese Medicine · CNShuguang Hospital · CNUniversity of California, Riverside · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Gina M Dayton · 2002 to 2026
$84.9M
Mitochondrial bioenergetics is associated with aggressive breast cancer growthR01CA213830 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LI, JIAN JIAN · 2017 to 2021
$1.8M
NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA213830
6 · The paper itself

Abstract

Saturated fatty acids (SFAs) (the "bad" fat), especially palmitate (PA), in the human diet are blamed for potential health risks such as obesity and cancer because of SFA-induced lipotoxicity. However, epidemiological results demonstrate a latent benefit of SFAs, and it remains elusive whether a certain low level of SFAs is physiologically essential for maintaining cell metabolic hemostasis. Here, we demonstrate that although high-level PA (HPA) indeed induces lipotoxic effects in liver cells, low-level PA (LPA) increases mitochondrial functions and alleviates the injuries induced by HPA or hepatoxic agent carbon tetrachloride (CCl

Indexed as

AnimalsCarbon TetrachlorideCarnitine O-PalmitoyltransferaseCDC2 Protein KinaseCells, CulturedChemical and Drug Induced Liver InjuryHepatocytesMaleMiceMice, Inbred C57BLMitochondriaPalmitatesSirtuin 3Carbon TetrachlorideCarnitine O-PalmitoyltransferaseCDC2 Protein KinaseCdk1 protein, mousePalmitatesSirt3 protein, mouseSirtuin 3CCl(4)CDK1CPT2fatty acid oxidationhepatotoxicitymetabolismmitochondriapalmitatesaturated fatty acidSIRT3

Identifiers

PMID31866205
PMCPMC6996588
OpenAlexW2994935207

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.